Concepedia

Danielle Boller

DB

Statistics

Publications

6

Citations

262

H-Index

6

Active since

2005

Affiliations

University Children's Hospital Zurich(Current)

Boston Children's Hospital

University Hospital of Zurich

Inserm

University of Bern

Danielle Boller is an author at University Children's Hospital Zurich specializing in medicine, cell signaling, and signal transduction.

Publications per year

2005–2014

6

Publications

6

Targeting the Phosphoinositide 3-Kinase Isoform p110δ Impairs Growth and Survival in Neuroblastoma Cells

Danielle Boller, Alexander Schramm, Kathrin T. Doepfner et al. · Clinical Cancer Research · 2008 · 75 citations · Full text

, , +17

Novel role for insulin as an autocrine growth factor for malignant brain tumour cells

Alexandre Arcaro, Kathrin T. Doepfner, Danielle Boller et al. · Biochemical Journal · 2007 · 48 citations · Full text

, , +13

Cell cycle inhibitors p21 and p16 are required for the regulation of Schwann cell proliferation

Suzana Atanasoski, Danielle Boller, Lukas De Ventura et al. · Glia · 2005 · 44 citations

, , +14

Targeting Class IA PI3K Isoforms Selectively Impairs Cell Growth, Survival, and Migration in Glioblastoma

Katrin Höland, Danielle Boller, Christian Hagel et al. · PLoS ONE · 2014 · 41 citations · Full text

, , +17

Targeting PI3KC2β impairs proliferation and survival in acute leukemia, brain tumours and neuroendocrine tumours.

Danielle Boller, Kathrin T. Doepfner, Angela De Laurentiis et al. · PubMed · 2012 · 32 citations

, , +17

1–5 of 6